Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Saturday, November 28, 2009, 7:57PM ET - U.S. Markets Closed. Dow Down 1.48% Nasdaq Down 1.73%
Keryx Biopharmaceuticals Inc. (KERX)On Nov 27: 2.38   0.00 (0.00%)  
MORE ON KERX
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
PERIOD ENDING31-Dec-0831-Dec-0731-Dec-06
Total Revenue1,283  1,049  534  
Cost of Revenue27  162  530  
Gross Profit1,256  887  4  
Operating Expenses
Research Development38,008  78,463  62,643  
Selling General and Administrative14,289  17,005  17,518  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss(51,041)(94,581)(80,157)
Income from Continuing Operations
Total Other Income/Expenses Net(1,665)4,555  6,393  
Earnings Before Interest And Taxes(52,706)(90,026)(73,764)
Interest Expense -   -   -  
Income Before Tax(52,706)(90,026)(73,764)
Income Tax Expense -  36   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(52,706)(90,062)(73,764)
Non-recurring Events
Discontinued Operations(175) -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income(52,881)(90,062)(73,764)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares($52,881)($90,062)($73,764)

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol: Symbol Lookup
Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More